Sp was decimated last few months...progress to clinics/hospitals much slower then expected. But with each new clinic and each new machine installed there will be growing nr of patients and increased recurring revenue....need to let them grow...we will get there...one day. The US markiet is clear even our own Australian is easy to understand (Medicare and private funds to refund for tests?). What about Europe with all differen countries and systems in place? Do we know anything how they going to deal with that? I know the priority is US but would like to know what is ahead.
IPD Price at posting:
38.0¢ Sentiment: Buy Disclosure: Held
